150
Participants
Start Date
December 31, 2007
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
Radezolid
450mg PO QD
Radezolid
450mg PO BID
Linezolid
600mg PO BID
Drug Research & Analysis Corp, Montgomery
OWENS Pharma Research Center, Long Beach
Healthcare Partners Medical Group, Los Angeles
HealthCare Partners Medical Group, Pasadena
Olive View- UCLA Center, Dept. Emergency Medicine, Sylmar
South Florida Clinical Research, Atlantis
Southeast Regional Research Group, Columbus
Contemporary Medicine, LLC, Hinesville
Infectious Disease of Indiana, PSC., Indianapolis
Clinical Trials of America, Inc., Shreveport
Arnold Markowitz, MD., PC, Keego Harbor
Mercury Street Medical Group, LLC, Butte
Jamaica Hospital Medical Center, Jamaica
ALL-TRIALS Clinical Research, LLC, Winston-Salem
Summa Health System, Akron
Brandywine Clinical Research, Downington
Warminster Medical Associates, P.C., Warminster
McKenzie Medical Center, McKenzie
J. Lewis Research, Inc., Salt Lake City
Lead Sponsor
Melinta Therapeutics, Inc.
INDUSTRY